Emergency Evaluation and Management of Headache with Vomiting in a 19-Year-Old
A 19-year-old presenting with headache and vomiting requires immediate non-contrast CT scan to rule out subarachnoid hemorrhage (SAH), followed by lumbar puncture if CT is negative and clinical suspicion remains high, before considering treatment for primary headache disorders like migraine. 1
Immediate Red Flag Assessment
The combination of headache and vomiting in a young adult demands urgent evaluation for life-threatening secondary causes before assuming a benign primary headache disorder. Key red flags to assess immediately include:
- Thunderclap onset (sudden, maximal intensity immediately) - highly suggestive of SAH 1
- "Worst headache of life" - reported by 80% of SAH patients who can give history 1
- Loss of consciousness (even brief) - present in 53% of SAH cases 1
- Nuchal rigidity - found in 35% of SAH patients 1
- Altered mental status or focal neurological deficits 2
- Fever - suggests intracranial infection 2
Critical pitfall: SAH is misdiagnosed in approximately 12% of cases, with misdiagnosis associated with nearly 4-fold higher likelihood of death or disability. The most common error is failure to obtain CT scan. 1
Diagnostic Algorithm
Step 1: Immediate Non-Contrast CT
- Perform immediately if any red flags present 1, 3
- CT sensitivity for acute SAH is 98% with 99% specificity 2
- Timing matters: CT sensitivity approaches 100% within first 3 days, then decreases sharply after 5-7 days 1
Step 2: Lumbar Puncture Decision
If CT is negative but clinical suspicion for SAH remains:
- Third-generation or higher CT performed within 6 hours of headache onset and read by neuroradiologist: lumbar puncture NOT required 3
- If lower generation CT, performed after 6 hours, not read by experienced radiologist, or patient has altered consciousness: lumbar puncture mandatory 3
- Xanthochromia evaluation most sensitive after minimum 12-hour delay from headache onset 3
Step 3: Vascular Imaging
If SAH confirmed, proceed immediately to CTA or catheter angiography to identify aneurysm 1, 3
Treatment for Primary Headache (After Excluding Secondary Causes)
For Moderate-to-Severe Migraine with Vomiting
First-line combination therapy (most effective approach):
Antiemetic adjunct (essential with vomiting):
- Metoclopramide 10mg IV/IM or prochlorperazine 10mg IV/IM 6, 7
- These provide dual benefit: treat nausea AND improve gastric motility impaired during migraine 6
- Add diphenhydramine 25-50mg to prevent dystonic reactions 7
Alternative if triptans contraindicated or failed:
- Gepants (rimegepant 75mg or ubrogepant 50-100mg) - newer CGRP antagonists 4, 8
- Ketorolac 30-60mg IV/IM - rapid onset, 6-hour duration, minimal rebound risk 6
Non-Oral Routes (Critical with Vomiting)
Use non-oral administration when vomiting present 6:
- Subcutaneous sumatriptan 6mg (most effective for rapid severe migraine) 5
- IV/IM metoclopramide or prochlorperazine
- IV ketorolac
- Intranasal sumatriptan or zolmitriptan (if injectable not available)
Medications to AVOID
Do NOT use opioids (meperidine, butorphanol) or butalbital-containing compounds 4, 5:
- Questionable efficacy
- High risk of dependency
- Promote medication overuse headache
- Rebound headaches common
Rescue Therapy for Refractory Cases
If above treatments fail in ED setting:
- IV dihydroergotamine (DHE) protocol 7
- Dexamethasone 10-20mg IV (prevents recurrence, not for acute pain) 7
- Divalproex sodium 500-1000mg IV 7
- Greater occipital nerve block (0.5% bupivacaine with corticosteroid) 8
Disposition Considerations
Admit for status migrainosus if:
- Headache persists >72 hours despite treatment
- Severe dehydration from vomiting
- Unable to tolerate oral medications
- Medication overuse headache suspected (using acute medications >10-15 days/month) 4
Discharge with:
- Clear return precautions for red flags
- Prescription for triptan + NSAID combination
- Antiemetic prescription
- Avoid medication overuse: limit acute treatment to ≤2 days per week 9
- Consider preventive therapy referral if attacks occur ≥2 days/month affecting quality of life 5
The evidence strongly supports early aggressive combination therapy over monotherapy or sequential treatment approaches, with non-oral routes essential when vomiting present. The 2025 ACP guideline 4 and 2021 consensus statement 5 both emphasize treating early with adequate doses rather than step-wise escalation, which delays relief and worsens outcomes.